We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.35% | 28.60 | 28.20 | 29.00 | 28.75 | 28.60 | 28.75 | 1,773,661 | 13:07:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 48.48M | -776k | -0.0011 | -260.00 | 193.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2019 14:01 | Well this is looking like a dead fish now. Cannot even get in contact with anyone at the company to ask investor questions to. | mertymcs | |
16/10/2019 17:49 | But note the RNS wording "No trading in the stock - voting control interest over stock transferred to new manager". This RNS wording is the same as several other WEIF companies.Yesterday' | tightfist | |
16/10/2019 10:09 | Looks like you were wrong "Applegarth", nothing new there then | discojames | |
16/10/2019 06:58 | Wait till woodys holding here is dumped into the markets ! SUB 2p in sights. FVCK you spurs777 | therealapplegarth | |
15/10/2019 21:31 | All Woody funds being closed and put into run down over time. Not sure where his 18% or 15M shares are held but happy to see the back of him. | loafofbread | |
10/10/2019 22:36 | Maybe this is why the U.S. want to spend $130million developing a universal flu vaccine? hxxps://www.nytimes. | muchodinero | |
30/9/2019 11:59 | hxxps://www.federalr | muchodinero | |
24/9/2019 16:32 | That's one thing we agree on, hoping Trevor will leave soon as he's been a real dissappointment with the handling of an asset like flu v and general shareholder contact and updates. Could do with a new head and a PR person/team. Hopefully a new CEO would be better at negotiation or have the foresight to bring in someone that is, but then again it could all be led by Seek - hvivo could be as frustrated as we are about the whole thing | discojames | |
24/9/2019 09:06 | think you're more likely to see see director byes than director buys | mister md | |
20/9/2019 16:40 | Did I miss the director buys? | loafofbread | |
19/9/2019 17:11 | because every share has that comment | babbler | |
19/9/2019 12:52 | why is that Babbler? | tonyw99 | |
19/9/2019 12:51 | Disco - they've spent that. Cash received from R&D credit on 4th Sept. Cash balance on the 6th £4.3m. Net inflows of £0.3m from July to Sept means outflows of £1.3m without the R&D rebate. They expect cash outflows throughout H2 and no booked work for H1 20 | tonyw99 | |
19/9/2019 12:29 | the going concern comments from people on shares always makes me smile. | babbler | |
19/9/2019 12:25 | Not quite true, they also made a net profit for that period of £0.3m (highly significant they are beginning to move to profit in my opinion), and have an R&D grant of £2.4m on top of that, so cash should be around £6.7m | discojames | |
19/9/2019 12:09 | They are close to running out of cash and they know it £4.0m at 6th Sept. The going concern statement isn't glowing either. | tonyw99 | |
19/9/2019 10:34 | yup one to buy if you have more than 5 minute view. | babbler | |
19/9/2019 10:05 | Trust the market to concentrate on the bad. All expenditure down, income up, on course for profitability in 2020 even with the failed contract which is beyond Hvivo control. | discojames | |
19/9/2019 09:25 | results weren't that bad. Losses down revenue up profitability next year. MMS concentrated on late contract cancellations. Despite that losses are down and margins up. | babbler | |
19/9/2019 09:02 | Nice quick 25% for anyone lucky enough to grab a few at the open. | azuli | |
19/9/2019 08:53 | that's a turnaround and a half! | qs99 | |
28/8/2019 11:00 | Has this just been kept smashed to the ground because of the Woodford 20% holding? | loafofbread |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions